| DBV TECHNOLOGIES EO -,10 |
| Frankreich |
| Gesundheit |
| FR0010417345 / A1JWB7 |
| DBV (Frankfurt) |
| FRA:DBV, ETR:DBV, DBV:GR |
| - |
| https://dbv-technologies... |
|
DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous patch that delivers allergens like peanut or milk..
>Volltext.. |
| 634.41 Mio. EUR |
| 507.3 Mio. EUR |
| - |
| -170.89 Mio. EUR |
| -182.4 Mio. EUR |
| -0.53 EUR |
| 19.96 Mio. EUR |
| 148.98 Mio. EUR |
| -165.79 Mio. EUR |
| 2.83 |
| - |
| -58.58% |
| - |
| - |
| - |
| - |
| DBV TECHNOLOGIES, DBV TECH |
| 13.11.26 |